News About: Pharm. Industry
Quality of Kyeongbo's Bacampicillin bulk approved in Europe.Kyeongbo Pharmaceutical company (President: Kim Young-eun) announced that the bulk of Bacampicillin Hcl, a semi-synthetic penicillin, had obtained its Certificate of Suitability...
|
Test on Rispedal to prove promising treatment of maniac patients.A new drug called Rispedal (risperidone) originally developed by Janssen was found very effective for mania in the treatment of manic-depressive patient when combining with an a...
|
Pfizer Korea's Plunazol-related claim for damage is unlikely to affect Daewoong Pharm
Hanyang Securities Co. said that Pfizer Korea submitted to Seoul District Court its claim for damage against patent infringement of Daewoong Pharm over Plunazol, which annualized domestic sales of 23.8 billion won las...
Novartis Korea to launch IBS medication in domestic marketNovartis Korea, a Korean unit of Switzerland-based multinational pharmaceutical firm, said it would soon roll out Zelmac (tegasorod) into domestic pharmaceutical market.
Te...
|
GSK Korea introduces PritorPlus, combination therapy of telmisartan plus HCTZGlaxoSmithKline Korea launched PritorPlus, a combination medication of telmisartan and diruretic hydrochlrorothiazide, in the domestic market on October 6 after approval from th...
|
Domestic pharmaceutical firms urged to step up systematic marketing approaches
Pharmaceutical business sources say that as competition is getting fiercer among drug makers including foreign-invested firms in domestic market, enhanced sales and marketing power via active investment is emerging as...
Chong Kun Dang looks to the future"To maximize the chances of discovering breakthrough products within the constraint of scarce resources has been extremely difficult to us in face of uncertainties and tremendou...
|
Daewoong Pharm to tender offer 30% of own shares
Daewoong Pharm Co., Korea's leading pharmaceutical manufacturer, plans to tender offer 30 percent of its own common shares in a bid to meet the legal requirement of Fair Trade Code Law on a holding company but the inf...
AstraZeneca Korea seeks to revamp domestic drug distribution channel via DSP
Pharmaceutical business sources say that AstraZeneca Korea's new concept based on distribution streamline project designed to ameliorate the current domestic drug distribution channel has drawn keen attention from the...
HIRA to scrutinize 765 most frequently prescribing drugs.
The Health Insurance Review Agency (HIRA) completed to set up the list on Oct. 8 covering 765 of the most expensive prescription drugs out of the total 9,840 items to be specially scrutinized its justification of the ...
